Verified against court and regulatory records · No upfront fees · Your information is never sold
Quick Eligibility Review
Answer one question at a time. This usually takes under 2 minutes.
Check your eligibility — free
Answer 2-3 quick questions to review your potential case.
Free · Confidential · About 2 minutes · A case specialist responds within 1 business day
Your answers are never sold or shared without your consent.
The Chemical Cocktail in Your Hair Relaxer
Chemical testing has identified at least 45 endocrine-disrupting or asthma-associated chemicals in hair relaxer products, spanning 10 chemical classes: phthalates (estrogen mimics), parabens (estrogen mimics), formaldehyde and releasing agents (carcinogens), bisphenol A/BPA (estrogen mimic), cyclosiloxanes D4 and D5 (endocrine disruptors, suspected carcinogens), heavy metals (lead, mercury, arsenic, cadmium), alkylphenols (estrogenic), glycol ethers (reproductive toxicants), UV filters (endocrine disruptors), and synthetic musks (estrogenic).
The Scalp Absorption Pathway
Hair relaxers work by applying strong alkaline chemicals (sodium hydroxide or calcium hydroxide) to break protein bonds in hair. These same chemicals damage the scalp's protective barrier — the stratum corneum — dramatically increasing percutaneous absorption of co-formulated EDCs. The burning sensation nearly all users experience confirms active barrier compromise. This broken-barrier pathway delivers chemicals directly into the bloodstream at far higher rates than intact-skin application.
The Labeling Failure
Testing found that 84% of EDCs detected in hair products were NOT disclosed on product labels. Consumers had no way to know what chemicals they were absorbing. Products marketed to children ("Just for Me") contained the same undisclosed EDCs. The labeling gap is central to the failure-to-warn claims.
Reducing Your Exposure
If you currently use chemical hair relaxers, consider transitioning to natural hairstyles, protective styles, or heat-based methods that don't involve chemical application. The Sister Study evidence applies specifically to chemical straightening products, not heat-based tools. Reducing frequency of chemical applications reduces cumulative EDC exposure.
Research & evidence
Scientific Evidence
Hair Relaxer Use and Risk of Uterine Cancer in the Black Women's Health Study
Bertrand KA, Coogan PF, Palmer JR (2023). Environmental Research
View on PubMedUse of Straighteners and Other Hair Products and Incident Uterine Cancer
Chang CJ, O'Brien KM, Keil AP, Gaston SA, Jackson CL, Sandler DP, White AJ (2022). Journal of the National Cancer Institute
View on PubMedUse of Hair Products in Relation to Ovarian Cancer Risk
White AJ, Sandler DP, et al. (2021). Carcinogenesis
View on PubMedFAQ
Frequently Asked Questions
Dive deeper
Related Guides
- Hair Relaxer Uterine CancerUterine cancer is the primary injury in the hair relaxer litigation. The NIH Sister Study found a 155% increased risk (HR 2.55) for frequent users. Approximately 67,000 Americans are diagnosed with uterine cancer annually.
- Hair Relaxer Ovarian CancerThe Sister Study found hair relaxer users face a 2.19x increased risk of ovarian cancer. Ovarian cancer is often called the "silent killer" because symptoms are vague until advanced stages, making early detection difficult.
- Hair Relaxer EndometriosisChemical hair relaxers contain EDCs linked to endometriosis — a painful condition where uterine-like tissue grows outside the uterus. Phthalates and parabens in relaxers promote endometrial implant growth through estrogen mimicry.
- Hair Relaxer Settlement AmountsNo hair relaxer cases have settled or gone to trial yet. Attorney estimates project $90,000–$1,000,000+ depending on injury type and severity. Bellwether trials expected in 2027 will establish actual case values.
- L'Oréal Hair Relaxer LawsuitL'Oréal is the primary defendant in the hair relaxer MDL through its subsidiary SoftSheen-Carson, maker of Dark & Lovely and Optimum Care. L'Oréal is the world's largest beauty company with €38+ billion in annual revenue.
- Revlon Dark and Lovely LawsuitRevlon is a defendant in the hair relaxer MDL despite filing bankruptcy in 2022. Revlon maintains insurance coverage and allocated ~$44 million for hair relaxer claims in its reorganization plan. Products include Creme of Nature and Revlon Realistic.
- Hair Relaxer Lawsuit Black WomenHair relaxer lawsuits disproportionately affect Black women, who were the primary marketing target, comprise 60% of affected users, and face twice the uterine cancer mortality rate of white women. This is both a product liability and a racial justice case.
The full investigation